Co-Authors
This is a "connection" page, showing publications co-authored by Claudio Marasca and Maria Annunziata.
Connection Strength
3.537
-
Coronavirus disease and dermatology: current and future challenges. G Ital Dermatol Venereol. 2020 Oct; 155(5):683-684.
Score: 0.227
-
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience. Support Care Cancer. 2020 Sep; 28(9):3991-3993.
Score: 0.222
-
Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic. J Eur Acad Dermatol Venereol. 2020 Jun; 34(6):e249.
Score: 0.221
-
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy. J Dermatolog Treat. 2022 Feb; 33(1):592.
Score: 0.221
-
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study J Drugs Dermatol. 2019 May 01; 18(5):437-438.
Score: 0.205
-
Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes". J Am Acad Dermatol. 2019 Mar 11.
Score: 0.203
-
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance. Br J Dermatol. 2019 04; 180(4):949.
Score: 0.201
-
Insulin resistance, mTOR and hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2019 03; 33(3):e106-e107.
Score: 0.198
-
Chemotherapy-induced periungual pyogenic granuloma: epidemiology and recurrence rates in our experience. G Ital Dermatol Venereol. 2018 Oct 11.
Score: 0.197
-
A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa. Open Access Maced J Med Sci. 2018 Oct 25; 6(10):1902-1905.
Score: 0.197
-
Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience. Clin Exp Dermatol. 2019 04; 44(3):e28-e29.
Score: 0.197
-
Unconventional therapies for hidradenitis suppurativa. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):879-887.
Score: 0.196
-
Hyperbaric oxygen therapy (HBOT )can improve the effectiveness of adalimumab in hidradenitis suppurativa. G Ital Dermatol Venereol. 2020 Apr; 155(2):234-235.
Score: 0.191
-
A misdiagnosed case of furuncular myiasis in an Italian traveler returning from Kenya. G Ital Dermatol Venereol. 2018 Apr; 153(2):288-289.
Score: 0.190
-
A case of axillary hidradenitis suppurativa treated with topical tacrolimus. G Ital Dermatol Venereol. 2019 Oct; 154(5):594-595.
Score: 0.188
-
Zoon Balanitis in an immune-competent teenager. G Ital Dermatol Venereol. 2019 Apr; 154(2):221-223.
Score: 0.183
-
Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects. Dermatol Ther. 2021 01; 34(1):e14677.
Score: 0.057
-
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast. Eur J Cancer. 2019 Mar; 110:107-109.
Score: 0.051
-
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience. G Ital Dermatol Venereol. 2020 Dec; 155(6):749-753.
Score: 0.049
-
Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018 Dec; 4(4):203-211.
Score: 0.048
-
Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results. Support Care Cancer. 2018 May; 26(5):1353-1355.
Score: 0.047
-
Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients. Open Access Maced J Med Sci. 2018 Jan 25; 6(1):31-34.
Score: 0.047